Table 1 Clinical characteristics of the 85 patients prior to the first ASCT
| Â | 85 patients, n (%) | |
|---|---|---|
Type MM | IgG kappa | 34 (40.0%) |
IgG Lambda | 14 (16.5%) | |
IgA kappa | 10 (11.8%) | |
IgA Lambda | 8 (9.4%) | |
Gammopathy with two monoclonal components | 4 (4.7%) | |
Light Chain MM | 11 (12.9%) | |
Non Secretor MM | 4 (4.7%) | |
ISS score | I | 15 (17.6%) |
II | 47 (55.3%) | |
III | 20 (23.5%) | |
Unknown | 3 (3.5%) | |
Durie-Salmon stage | IA | 7 (8.2%) |
IIA | 16 (8.8%) | |
IIIA | 49 (57.6%) | |
IIB | 3 (3.5%) | |
IIIB | 10 (11.8%) | |